Portable mesh nebulizers make breathing treatment simpler when life (or symptoms) gets messy. Unlike inhalers that demand ...

If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you ...

Patients at high risk for AECOPD were more likely to receive guideline concordant medications, and progressively more patients received such care over time. In chronic obstructive pulmonary disease ...

Abstract: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the world, and doctors expect the number of patients to increase by 23% in 2050. Patients experience ...

LA JOLLA, Calif.--(BUSINESS WIRE)--#Biotech--AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory ...

Nebulizers and automatic cars have something in common. They are both designed to facilitate the smooth operation of something essential. A 2022 article in the Wall Street Journal indicated that only ...

GSK plc GSK announced that the FDA has approved its blockbuster respiratory drug, Nucala (mepolizumab), for a fifth indication. The drug is now cleared to treat certain patients with chronic ...

COPD Risk Confirmed: Exclusive e-cigarette use is significantly associated with new cases of chronic obstructive pulmonary disease. Hypertension Warning: A modest increase in high blood pressure was ...

A Johns Hopkins Medicine-led analysis of medical information gathered on a diverse group of almost 250,000 people over four years has significantly clarified the link between the "exclusive" use of ...